Multidisciplinary team approach for the management of patients with locally advanced non-small cell lung cancer: searching the evidence to guide the decision
In-Jae Oh, Sung-Ja Ahn
Radiat Oncol J. 2017;35(1):16-24.   Published online 2017 Mar 31     DOI:
Citations to this article as recorded by Crossref logo
Carbon-ion radiotherapy for octogenarians with locally advanced non-small-cell lung cancer
Kazuhiko Hayashi, Naoyoshi Yamamoto, Mio Nakajima, Akihiro Nomoto, Hitoshi Ishikawa, Kazuhiko Ogawa, Hiroshi Tsuji
Japanese Journal of Radiology.2021;[Epub]     CrossRef

Low Prognostic Nutritional Index Predicts Poor Clinical Outcomes in Patients with Stage IIIB Non-small-cell Lung Carcinoma Undergoing Chemoradiotherapy

Yurday Ozdemir, Erkan Topkan, Huseyin Mertsoylu, Ugur Selek
Cancer Management and Research.2020; Volume 12: 1959.     CrossRef
Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer
Priyanka Bobbili, Kellie Ryan, Maral DerSarkissian, Akanksha Dua, Christopher Yee, Mei Sheng Duh, Jorge E. Gomez, Jason Chia-Hsun Hsieh
PLOS ONE.2020; 15(3): e0230444.     CrossRef
Clinical outcomes of carbon‐ion radiotherapy for locally advanced non‐small‐cell lung cancer
Kazuhiko Hayashi, Naoyoshi Yamamoto, Mio Nakajima, Akihiro Nomoto, Hiroshi Tsuji, Kazuhiko Ogawa, Tadashi Kamada
Cancer Science.2019; 110(2): 734.     CrossRef
Less of a good thing – the paradox of reduced multidisciplinary team decision-making
Sasan Partovi, David Sin, Amanjit Gill
Vasa.2019; 48(3): 203.     CrossRef
High-Dose Thoracic Re-irradiation of Lung Cancer Using Highly Conformal Radiotherapy Is Effective with Acceptable Toxicity
Ji Hyun Hong, Yeon-Sil Kim, Sea-Won Lee, So Jung Lee, Jin Hyung Kang, Suk Hee Hong, Ju-Young Hong, GeumSeong Cheon
Cancer Research and Treatment.2019; 51(3): 1156.     CrossRef
TGFβ pathway inhibition in the treatment of non-small cell lung cancer
Pınar Ö. Eser, Pasi A. Jänne
Pharmacology & Therapeutics.2018; 184: 112.     CrossRef
Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study†
Nicola Tamburini, Pio Maniscalco, Sara Mazzara, Elisa Maietti, Alessandra Santini, Nunzio Calia, Antonio Stefanelli, Antonio Frassoldati, Ivan Santi, Rosa Rinaldi, Fares Nigim, Riccardo Righi, Stefania Pedrazzi, Giorgio Cavallesco
European Journal of Cardio-Thoracic Surgery.2018; 53(6): 1199.     CrossRef
Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis
C. Lange, W. A. Alghamdi, M. H. Al-Shaer, S. Brighenti, A. H. Diacon, A. R. DiNardo, H. P. Grobbel, M. I. Gröschel, F. von Groote-Bidlingmaier, M. Hauptmann, J. Heyckendorf, N. Köhler, T. A. Kohl, M. Merker, S. Niemann, C. A. Peloquin, M. Reimann, U. E. S
Journal of Internal Medicine.2018; 284(2): 163.     CrossRef
Radical radiotherapy or chemoradiotherapy for inoperable, locally advanced, non-small cell lung cancer: Analysis of patient profile, treatment approaches, and outcomes for 213 patients at a tertiary cancer center
RajKumar Shrimali, Chandran Nallathambi, Animesh Saha, Avipsa Das, Sriram Prasath, Anurupa Mahata, B Arun, Indranil Mallick, Rimpa Achari, Deepak Dabkara, Robin Thambudorai, Sanjoy Chatterjee
Indian Journal of Cancer.2018; 55(2): 125.     CrossRef
IL‑17 induces NSCLC A549 cell proliferation via the upregulation of HMGA1, resulting in an increased cyclin D1 expression
Chenhui Zhao, Yongting Li, Weiming Zhang, Dan Zhao, Ling Ma, Pei Ma, Fengming Yang, Yingwei Wang, Yongqian Shu, Wen Qiu
International Journal of Oncology.2018;[Epub]     CrossRef
Application of the new 8th TNM staging system for non-small cell lung cancer: treated with curative concurrent chemoradiotherapy
Hoon Sik Choi, Bae Kwon Jeong, Hojin Jeong, Yun Hee Lee, In Bong Ha, Jin Ho Song, Ki Mun Kang
Radiation Oncology.2017;[Epub]     CrossRef